Mark Beards

Mark has over 25 years’ experience in the life sciences and financial sectors within global organisations and early stage companies. Mark spent 11 years in various roles within Abbott Laboratories then GlaxoSmithKline, across various commercial and R&D functions, before joining McKinsey & Company as a management consultant focused on supporting senior pharmaceutical clients. He then moved to Goldman Sachs as Vice President and Head of European Healthcare Equity Research, before moving back into senior consulting roles at Charles River Associates (VP, Life Science Strategy), and KPMG (Director, Life Science Strategy).

Immediately prior to joining UTILITY, Mark was Corporate Development Director, then Group Chief Financial Officer and Executive Board Member of Celixir plc, a clinical stage biotechnology company focused on developing cellular therapies. Mark holds a BA (Hons) and MA in Mathematics from The Queen’s College, Oxford University, and is a fully qualified Chartered Management Accountant.